Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tuberous Sclerosis × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Small Cell Lung Carcinoma 3 Rectal Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Fibrosis 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Sprains and Strains 1 Smoldering Multiple Myeloma 1 Sepsis 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Everolimus 14 Sirolimus 13 radiprodil 3 ganaxolone 3 Cannabidiol 3 Activator Appliances 3 Vigabatrin 2 Melatonin 2 exemestane 1 dactolisib 1 carbon-11 acetate 1 Surveys and Questionnaires 1 Simvastatin 1 Propranolol 1 Itraconazole 1 Injections 1 Fluid Therapy 1 Doxycycline 1 Curcumin 1 Carbamazepine 1 Calcitriol 1 Aspirin 1 Anticonvulsants 1 Actigraphy 1 Acceptance and Commitment Therapy 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡